通过Ran GTPase调节RCC1的亚细胞蛋白位址,驱动胰腺管道腺癌的生长
Sahar F Bannoura1, Amro Aboukameel1, Husain Yar Khan1
1Department of Oncology, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
Cancer letters
|September 25, 2024
概括
染色体凝聚1调节剂 (RCC1) 在胰腺癌中升高,并驱动瘤生长. 沉默RCC1可以抑制PDAC的进展,并使细胞对化疗敏感,从而揭示出潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 胰腺管腺癌 (PDAC) 是一种致命的癌症,治疗选择很少.
- 染色体凝聚1 (RCC1) 调节器对于核细胞质运输至关重要.
- 在PDAC病原发生过程中RCC1的作用在很大程度上是未被探索的.
研究的目的:
- 研究RCC1在PDAC中的功能.
- 确定RCC1是否是PDAC的可行的治疗标.
主要方法:
- 在PDAC组织中分析RCC1表达.
- 使用RNAi和CRISPR-Cas9.9进行RCC1淘汰 (KD) 和淘汰 (KO).
- 细胞增殖,迁移,克隆原性,细胞亡和细胞周期的测试.
- 转录和蛋白质组分析.
- 在体内瘤异种移植研究.
- 在RCC1 KD后评估凝素敏感性.
主要成果:
- 在PDAC中,RCC1的表达被上调,与预后不佳有关.
- RCC1 KD/KO减少了PDAC细胞的增殖,迁移和克隆性.
- RCC1 KD/KO改变细胞周期,增强细胞亡,并破坏Ran GTPase的局部化.
- RCC1通过PTK7影响Wnt信号传递,并影响新陈代谢途径.
- 在体内,RCC1 KO可以减少瘤的生长.
- RCC1 KD使PDAC细胞对凝素产生敏感.
结论:
- 在PDAC的发展和进展中,RCC1起着重要的作用.
- 向RCC1代表了PDAC的新治疗策略.
- 抑制RCC1可以提高对标准化疗的敏感性.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Directionality of Nuclear Transport
3.2K
Ras-related nuclear protein or Ran is a small G protein that cycles between its GTP and GDP bound states. Ran specific regulators, a Ran GTPase Activating Protein or RanGAP present in the cytosol and a Ran guanine nucleotide exchange factor or RanGEF present inside the nucleus regulate GTP/GDP exchange. A high concentration of GTP inside the cells, in addition to this asymmetric distribution of Ran-specific regulators, leads to a higher RanGTP concentration inside the nucleus. This...
3.2K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
GTPases and their Regulation
8.3K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
8.3K


